Myocyte death and growth in the failing heart

Laboratory Investigation

Volumn 78, Issue 7, 1998, Pages 767-786

  Anversa, Piero ^a   Leri, Annarosa ^a   Beltrami, Carlo Alberto ^b   Guerra, Sabrina ^a   Kajstura, Jan ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53; SOMATOMEDIN C;

APOPTOSIS; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARDIOMEGALY; CARDIOMYOPATHIES; CELL DEATH; CELL DIVISION; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031848310     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (208)

1. Agah R, Kirshenbaum LA, Abdellatif M, Truong LD, Chakraborty S, Michael LH, and Schneider MD (1997). Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest 100:2722-2728.
2. Anversa P, Beghi C, Kikkawa Y, and Olivetti G (1986a). Myocardial infarction in rats: Infarct size, myocyte hypertrophy, and capillary growth. Cire Res 58:26-37.
3. Anversa P and Kajstura J (in press, 1998a). Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res.
4. Anversa P, Kajstura J, Cheng W, Reiss K, Cigola E, and Olivetti G (1996a). Insulin-like growth factor-1 and myocyte growth: The danger of a dogma. Part I. Postnatal myocardial development: Normal growth. Cardiovasc Res 32:219-225.
5. Anversa P, Kajstura J, Cheng W, Reiss K, Cigola E, and Olivetti G (1996b). Insulin-like growth factor-1 and myocyte growth: The danger of a dogma. Part II. Induced myocardial growth: Pathologic hypertrophy. Cardiovasc Res 32:484-495.
6. Anversa P, Li P, Zhang X, Olivetti G, and Capasso JM (1993a). Ischemic myocardial injury and ventricular remodeling. Cardiovasc Res 27:145-157.
7. Anversa P and Olivetti G (in press, 1998b). Cellular basis of physiologic and pathologic myocardial growth. In: Page E, Fozzard HA, and Solaro RJ, editors. Handbook of physiology, section 2: The cardiovascular system: The heart, vol 1. Oxford, England: Oxford University Press.
8. Anversa P, Olivetti G, Leri A, Liu Y, and Kajstura J (1997). Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens 6:169-176.
9. Anversa P, Olivetti G, and Loud AV (1980). Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. I. Hypertrophy, hyperplasia, and binucleation of myocytes. Circ Res 46:495-502.
10. Anversa P, Olivetti G, and Loud AV (1983). Morphometric studies of left ventricular hypertrophy. In: Tarazi RC and Dunbar JB, editors. Perspectives in cardiovascular research: Cardiac hypertrophy in hypertension. New York: Raven Press, 27-39.
11. Anversa P, Olivetti G, Meggs LG, Sonnenblick EH, and Capasso JM (1993b). Cardiac anatomy and ventricular loading after myocardial infarction. Circulation 87:VII22-VII27.
12. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, and Capasso JM (1990). Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 67:871-885.
13. Anversa P, Ricci R, and Olivetti G (1986b). Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: A review. J Am Coll Cardiol 7:1140-1149.
14. Anversa P, Zhang X, Li P, and Capasso JM (1992). Chronic coronary artery constriction leads to moderate myocyte loss and left ventricular dysfunction and failure in rats. J Clin Invest 89:618-629.
15. Arbustini E, Pozzi R, Grasso M, Gavazzi A, Diegoli M, Bramerio M, Graziano G, Campana C, Angoli L, DeServi S, Martinelli L, Goggi C, Vigano M, and Specchia G (1991). Pathologic substrates and clinical correlates of coronary artery disease and chronic congestive heart failure requiring cardiac transplantation. Coron Artery Dis 2:605-612.
16. Astorri E, Bolognesi R, Colla B, Chizzola A, and Visioli O (1977). Left ventricular hypertrophy: A cytometric study on 42 human hearts. J Mol Cell Cardiol 9:763-775.
17. Astorri E, Chizzola A, Visioli O, Anversa P, Olivetti G, and Vitali-Massa L (1971). Right ventricular hypertrophy: A cytometric study on 55 human hearts. J Mol Cell Cardiol 2:99-110.
18. Bardales RH, Hailey S, Xie SS, Schaefer RF, and Hsu S-M (1996). In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol 149:821-829.
19. Beltrami CA, Di Loreto C, Finato N, Rocco M, Artico D, Cigola E, Gambert SR, Olivetti G, Kajstura J, and Anversa P (1997). Proliferating cell nuclear antigen (PCNA), DNA synthesis and mitosis in myocytes following cardiac transplantation in man. J Mol Cell Cardiol 29:2789-2802.
20. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, and Anversa P (1994). Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89:151-163.
21. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick EH, Olivetti G, and Anversa P (1995). The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 27:291-305.
22. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, and Clark WA (1989). Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 67:657-670.
23. Bialik S, Geenen DL, Sasson IE, Cheng R, Horner JW, Evans SM, Lord EM, Koch CJ, and Kitsis RN (1997). Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 100:1363-1372.
24. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, and Lefer AM (1995). Cardioprotective effect of insulin-like growth factor 1 in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 92:8031-8035.
25. Buja LM and Willerson JT (1987). The role of coronary artery lesions in ischemic heart disease: Insight from recent clinicopathologic, coronary arteriographic, and experimental studies. Hum Pathol 18:451-461.
26. Bursch W, Oberhammer F, and Schulte-Hermann R (1992). Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 13:245-251.
27. Capasso JM, Li P, and Anversa P (1993). Cytosolic calcium transients in myocytes isolated from rats with ischemic heart failure. Am J Physiol 265:H1953-H1964.
28. Capasso JM, Palackal T, Olivetti G, and Anversa P (1990). Left ventricular failure induced by long-term hypertension in rats. Circ Res 66:1400-1412.
29. Ras in Ras-induced apoptosis. J Biol Chem 271:2376-2379.
30. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivetti G, and Anversa P (1996). Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226:316-327.
31. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, and Anversa P (1995a). Stretch induced programmed myocyte cell death. J Clin Invest 96:2247-2259.
32. Cheng W, Reiss K, Kajstura J, Kowal K, Quaini F, and Anversa P (1995b). Downregulation of the IGF-1 system parallels the attenuation in the proliferative capacity of rat ventricular myocytes during postnatal development. Lab Invest 72:646-655.
33. Chien KR, Knowlton KU, Zhu H, and Chien S (1991). Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response. FASEB J 55:3037-3046.
34. Chun SY, Billig H, Tilly JL, Furuta I, Tsafriri A, and Hsueh AJ (1994). Gonadotropin suppression of apoptosis in cultured preovulatory follicles: Mediatory role of endogenous insulin-like growth factor 1. Endocrinology 135:1845-1853.
35. Cigola E, Kajstura J, Li B, Meggs LG, and Anversa P (1997). Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res 231:363-371.
36. Clubb FJ Jr, and Bishop SP (1984). Formation of binucleated myocardial cells in the neonatal rat. An index for growth hypertrophy. Lab Invest 50:571-577.
37. Colucci WS (1996). Apoptosis in the heart. N Engl J Med 335:1224-1226.
38. Cusick ME, Wassarman PM, and DePamphilis ML (1989). Application of nucleases to visualizing chromatin organization at replication forks. Methods Enzymol 170:290-316.
39. D'Mello SR, Borodezt K, and Soltoff SP (1997). Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: Possible involvement of PI3-kinase in IGF-1 signaling. J Neurosci 17:1548-1560.
40. D'Mello SR, Galli C, Ciotti T, and Calissano P (1993). Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor 1 and cAMP. Proc Natl Acad Sci USA 90:10989-10993.
41. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, and Traganos F (1992). Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808.
42. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, and Traganos F (1997). Cytometry in cell necrobiology. Analysis of apoptosis, accidental cell death and necrosis. Cytometry 27:1-20.
43. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, and Greenberg ME (1997). Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
44. DeFelice A, Frering R, and Horan P (1989). Time course of hemodynamic changes in rats with healed severe myocardial infarction. Am J Physiol 257:H289-H296.
45. Didenko VV and Hornsby PJ (1996). Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol 135:1369-1376.
46. Diez J, Panizo A, Hernández M, Vega F, Sola I, Fortuño MA, and Pardo J (1997). Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 30:1029-1034.
47. Dimmeler S and Zeiher AM (1997). Nitric oxide and apoptosis: Another paradigm for the double-edged role of nitric oxide. NITRIC OXIDE 1:275-281.
48. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RS, Kaplan DR, and Greenberg ME (1997). Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661-665.
49. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, and Nagata S (1998). A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50.
50. Farrow SN and Brown R (1996). New members of the Bcl-2 family and their protein partners. Curr Opin Genet Dev 6:45-49.
51. Fliss H and Gattinger D (1996). Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79:949-956.
52. Franke TF, Kaplan DR, and Cantley LC (1997). PI3K: Down-stream AKTion blocks apoptosis. Cell 88:435-437.
53. Frishman WH, Nadelmann J, Ooi WL, Greenberg S, Heiman M, Kahn S, Guzik H, Lazar EJ, and Aronson M (1992). Cardiomegaly on chest x-ray: Prognostic implications from a ten-year cohort study of elderly subjects - A report from the Bronx Longitudinal Aging Study. Am Heart J 124:1026-1030.
54. Gerschenson LE and Rotello RJ (1992). Apoptosis: A different type of cell death. FASEB J 6:2450-2455.
55. Ginzton LE, Conant R, Rodriques DM, and Laks MM (1989). Functional significance of hypertrophy of the noninfarcted myocardium after myocardial infarction in humans. Circulation 80:816-822.
56. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, and Lassmann H (1994). Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71: 219-225.
57. Gorczyca W, Bruno S, Darzynkiewicz RJ, Gong J, and Darzynkiewicz Z (1992). DNA strand breaks occurring during apoptosis: Their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol 1:639-648.
58. Gorczyca W, Gong J, Ardelt B, Traganos F, and Darzynkiewicz Z (1993). The cell cycle related differences in susceptibility of HL-60 cell to apoptosis induced by various antitumor agents. Cancer Res 53:3186-3192.
59. Gottlieb RA, Burleson KO, Kloner RA, Babvior BM, and Engler RL (1994). Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94:1621-1628.
60. Gottlieb RA, Gruol DL, Zhu JY, and Engler RL (1996). Preconditioning in rabbit cardiomyocytes. Role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest 97:2391-2398.
61. Grajek S, Lesiak M, Pyda M, Zajac M, Paradowski S, and Kaczmarek E (1993). Hypertrophy or hyperplasia in cardiac muscle: Postmortem human morphometric study. Eur Heart J 14:40-47.
62. Grossman W, Carabello BA, Gunther S, and Fifer MA (1983). Ventricular wall stress and the development of cardiac hypertrophy and failure. In: Alpert NR, editor. Perspectives in cardiovascular research: Myocardial hypertrophy and failure. New York: Raven Press, 1-18.
63. Grossman W, Jones D, and McLaurin LP (1975). Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56:56-64.
64. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, and Nadal-Ginard B (1993). Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
65. Gwathmey JK, Bentivegna LA, Ransil BJ, Grossman W, and Morgan JP (1993). The relationship of abnormal intracellular calcium mobilization to myocyte hypertrophy in human ventricular myocardium. Cardiovasc Res 27:199-203.
66. Gwathmey JK, Copelas L, Makinnon R, Shoen FJ, Feldman MD, Grossman W, and Morgan JP (1987). Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61:70-76.
67. 2+ sensitivity in intact and skinned muscles from normal and diseased human myocardium. Circ Res 67:744-752.
68. Haendeler J, Weiland U, Zeiher AM, and Dimmeler S (1997). Effects of redox-related congeners of NO on apoptosis and caspase-3 activity. NITRIC OXIDE 1:282-293.
69. Haldar S, Jena N, and Croce CM (1995). Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4507-4511.
70. Hamet P, Richard L, Dam TV, Teiger E, Orlov SM, Gaboury L, Gossard F, and Tremblay J (1995). Apoptosis in target organs of hypertension. Hypertension 26:642-648.
71. Hanada M, Aime-Sempe C, Sato T, and Reed JC (1995). Structure-function analysis of Bcl-2 protein: Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J Biol Chem 270: 11962-11969.
72. Harrington EA, Bennett MR, Fanidi A, and Evan GI (1994). c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295.
73. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, and Korsmeyer SJ (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
74. Holzman E (1989). Lysosomes. New York: Plenum Press.
75. Hu G (1993). DNA polymerase-catalyzed addition of nontemplated extra nucleotides to the 3′ end of a DNA-fragment. DNA Cell Biol 12:763-770.
76. Itoh G, Tamura J, Suzuki M, Suzuki Y, Ikeda H, Kioke M, Nomura M, Jie T, and Ito K (1995). DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 146:1235-1331.
77. Kajstura J, Cheng W, Reiss K, and Anversa P. (1994a). The IGF-1-IGF-1 receptor system modulates myocyte proliferation but not myocyte cellulary hypertrophy in vitro. Exp Cell Res 215:273-283.
78. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, and Anversa P. (1996a). Apoptotic and necrotic myocyte cell death are independent contributing variables of infarct size in rats. Lab Invest 74:86-107.
79. Kajstura J, Cheng W, Sarangarajan R, Li P, Li B, Nitahara JA, Chapnick S, Reiss K, Olivetti G, and Anversa P. (1996b). Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol 217:H1215-H1228.
80. Kajstura J, Zhang X, Liu Y, Szoke E, Cheng W, Olivetti G, Hintze TH, and Anversa P (1995). The cellular basis of pacing-induced dilated cardiomyopathy: Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 92: 2306-2317.
81. Kajstura J, Zhang X, Reiss K, Szoke E, Li P, Lagrasta C, Cheng W, Darzynkiewicz Z, Olivetti G, and Anversa P. (1994b). Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res 74:383-400.
82. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, and Anversa P (1997). Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 29:859-870.
83. Kardami E (1990). Stimulation and inhibition of cardiac myocyte proliferation in vitro. Mol Cell Biochem 92:129-135.
84. Karsner HT, Saphir O, and Todd TW (1925). The state of the cardiac muscle in hypertrophy and atrophy. Am J Pathol 1:351-371.
85. Katzberg AA, Farmer BB, and Harris RA (1977). The predominance of binucleation in isolated rat heart myocytes. Am J Anat 149:489-500.
86. Keith CT and Schreiber SL (1995). PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 270:50-51.
87. Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN, and Hay N (1997). The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11: 701-713.
88. Keul J, Dickhuth HH, Simon G, and Lehmann M (1981). Effect of static and dynamic exercise of heart volume, contractility and left ventricular dimensions. Circ Res 48:163-170.
89. Kirshenbaum LA, Abdellatif M, Chakraborty S, and Schneider MD (1996). Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev Biol 179:402-411.
90. Kirshenbaum LA and Schneider MD (1995). The cardiac cell cycle, pocket proteins and p300. Trends Cardiovasc Med 5:230-235.
91. Kloner RA, Ganote CE, Whalen D, and Jennings RB (1974). Effect of a transient period of ischemia on myocardial cells: II. Fine structure during the first few minutes of reflow. Am J Pathol 74:399-422.
92. Krajewski S, Tanaka S, Takayama S, Shibler M, Fenton W, and Reed J (1993). Investigations of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondnal membrane. Cancer Res 53:4701-4714.
93. Kulik G, Klippel A, and Weber MJ (1997). Antiapoptotic signaling by the insulin-like growth factor 1 receptor, phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 17:1595-1606.
94. 1-adrenergic stimulation. J Biol Chem 269:13490-13496.
95. Lauer MS, Evans JC, and Levy D (1992). Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol 70:1180-1184.
96. Lee H, Henderson S, Reynolds R, Dunnmon P, Yuan D, and Chien KR (1988). α-1 adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells: Effects on myosin light chain-2 gene expression. J Biol Chem 263: 7352-7358.
97. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, and Anversa P (1998a). Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2 to Bax protein ratio in the cell. J Clin Invest 101:1326-1342.
98. Leri A, Liu Y, Malhotra A, Li Q, Stiegler P, Claudio PP, Giordano A, Kajstura J, Hintze TH, and Anversa P. (1998b). Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation 97:194-203.
99. Li P, Hofmann PA, Li B, Malhotra A, Cheng W, Sonnenblick EH, Meggs LG, and Anversa P (1997a). Myocardial infarction alters myofilament calcium sensitivity and mechanical behavior of myocytes. Am J Physiol 272:H360-H370.
100. Li P, Park C, Micheletti R, Li B, Cheng W, Sonnenblick EH, Anversa P, and Bianchi G (1995). Myocyte performance during evolution of myocardial infarction in rats: Effects of propionyl-L-carnitine. Am J Physiol 268:H1702-H1713.
101. Li P, Zhang X, Capasso JM, Meggs LG, Sonnenblick EH, and Anversa P (1993). Myocyte loss and left ventricular failure characterize the long term effects of coronary artery narrowing or renal hypertension in rats. Cardiovasc Res 27:1066-1075.
102. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, and Anversa P (1997b). Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100:1991-1999.
103. Li Z, Bing OHL, Long X, Robinson KG, and Lakatta EG (1997c). Increased cardiomyocyte apoptosis during the transition of heart failure in the spontaneously hypertensive rat. Am J Physiol 272:H2313-H2319.
104. Liao R, Nascimben L, Friedrich J, Gwathmey JK, and Ingwall JS (1996). Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res 78:893-902.
105. Linzbach AJ (1960). Heart failure from the point of view of quantitative anatomy. Am J Cardiol 5:370-382.
106. Liu X, Zou H, Slaughter C, and Wang X (1997). DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175-184.
107. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, and Anversa P (1995). Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab invest 73:771-787.
108. Long X, Boluyt MO, de Lourdes Hipolito M, Lundberg MS, Zheng JS, O'Neill L, Cirielli C, Lakatta EG, and Crow MT (1997). p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 99:2635-2643.
109. Long X, Crow MT, Sollott SJ, O'Neill L, Menees DS, de Lourdes Hipolito M, Boluyt MO, Asai T, and Lakatta EG (1998). Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes. J Clin Invest 101:1453-1461.
110. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert ED, and Bristow MR (1997). Changes in gene expression in the intact human heart. Downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 100:2315-2324.
111. Lutter LC (1979). Precise location of DNase I cutting sites in the nucleosome core determined by high resolution gel electrophoresis. Nucleic Acids Res. 6:41-56.
112. MacLellan WR and Schneider MD (1997). Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 81:137-144.
113. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, and Fontaine G (1996). Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335:1190-1196.
114. 2+. Oncogene 12:2259-2266.
115. Matthews CC and Feldman EL (1996). Insulin-like growth factor 1 rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J Cell Physiol 166:323-331.
116. May WS, Tyler PG, Ito T, Armstrong DK, Qatsha KA, and Davidson NE (1994). lnterleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2a in association with suppression of apoptosis. J Biol Chem 269:26865-26870.
117. McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Come GC, Nakao C, Alderman JD, Ferguson JJ, Safian RD, and Grossman W (1986). Left ventricular remodeling after myocardial infarction: A corollary to infarct expansion. Circulation 74: 693-702.
118. Mirsky I (1969). Left ventricular stresses in the intact human heart. Biophys J 9:189-208.
119. Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, and Fujiwara H (1996). Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of humans with myocardial infarction. Circulation 94:1506-1512.
120. Miyashita T, Harigai M, Hanada M, and Reed JC. (1994a). Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131-3135.
121. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Huffman B, Lieberman D, and Reed JC. (1994b). Tumor suppressor p53 is a regulator of bcl-2 and bax in gene expression in vitro and in vivo. Oncogene 9:1799-1805.
122. Miyashita T and Reed J (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
123. Morgan P (1991). Mechanisms of disease: Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325:625-632.
124. L, an inhibitor of programmed cell death. Nature 381: 335-341.
125. Mundle SD and Raza A (1995). The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis. Lab Invest 72:611-612.
126. Nadal-Ginard B and Mahdavi V (1989). Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J Clin Invest 84:1693-1700.
127. Nakao K, Minobe W, Roden R, Bristow MR, and Leinwand LA (1997). Myosin heavy chain gene expression in human heart failure. J Clin Invest 100:2362-2370.
128. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, and Khaw BA (1996). Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182-1189.
129. Nitahara JA, Cheng W, Liu Y, Li B, Leri A, Li P, Mogul D, Gambert SR, Kajstura J, and Anversa P (1998). Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats. J Mol Cell Cardiol 30:519-535.
130. Nolan AC, Clark WA, Karwoski T, and Zak R (1983). Patterns of cellular injury in myocardial ischemia determined by monoclonal antimyosin. Proc Natl Acad Sci USA 80:6046-6050.
131. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, and Anversa P (1997). Apoptosis in the failing human heart. N Engl J Med 336:1131-1141.
132. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, and Anversa P (1991). Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 68:856-869.
133. Olivetti G, Capasso JM, Sonnenblick EH, and Anversa P (1990). Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res 67:23-34.
134. Olivetti G, Cigola E, Maestri R, Corradi D, Lagrasta C, Gambert SR, and Anversa P (1996a). Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the pro-portion of mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol 28:1463-1477.
135. Olivetti G, Melissari M, Balbi T, Quaini F, Cigola E, Sonnenblick EH, and Anversa P (1994a). Myocyte cellular hypertrophy is responsible for ventricular remodeling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure. Cardiovasc Res 28:1199-1208.
136. Olivetti G, Melissari M, Balbi T, Quaini F, Sonnenblick EH, and Anversa P (1994b). Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans. J Am Coll Cardiol 24:140-149.
137. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, Gambert SR, Cigola E, and Anversa P. (1996b). Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 28:2005-2016.
138. Oltvai ZN and Korsmeyer SJ (1994). Checkpoints of dueling dimers foil death wishes. Cell 79:189-192.
139. Oltvai ZN, Milliman CL, and Korsmeyer SJ (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619.
140. Page DL, Caulfield JB, Kastor JA, DeSancitis RW, and Sanders CA (1971). Myocardial changes associated with cardiogenic shock. N Engl J Med 285:133-137.
141. Page E (1978). Quantitative ultrastructural analysis in cardiac membrane physiology. Am J Physiol 235:C147-C158.
142. Pantely GA and Bristow JD (1984). Ischemic cardiomyopathy. Prog Cardiovasc Dis 27:95-114.
143. Parker TG and Schneider MD (1991). Growth factors, protooncogenes, and plasticity of the cardiac phenotype. Annu Rev Physiol 53:179-200.
144. Pfeffer MA and Braunwald E (1990). Ventricular remodeling after myocardial infarction. Circulation 81:1161-1172.
145. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, and Braunwald E (1988). Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319:80-86.
146. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, and Braunwald E (1979). Myocardial infarct size and ventricular function in rats. Circ Res 44:503-512.
147. Pfeffer MA, Pfeffer JM, Fletcher PJ, and Braunwald E (1991). Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 260:H1406-H1414.
148. Pfeffer MA, Pfeffer JM, Steinberg C, and Finn P (1985). Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril. Circulation 72:406-412.
149. Pierzchalski P, Reiss K, Cheng W, Cirielli C, Kajstura J, Nitahara JA, Rizk M, Capogrossi MC, and Anversa P (1997). p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp Cell Res 234:57-65.
150. Polyak K, Xia Y, Zweir JL, Kinzler KW, and Vogelstein B (1997). A model for p53-induced apoptosis. Nature 389:300-305.
151. Quaini F, Cigola E, Lagrasta C, Saccani G, Quaini E, Rossi C, Olivetti G, and Anversa P (1994). End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res 75:1050-1063.
152. Rakusan K, Flanagan MF, Geva T, Southern J, and Van Praagh R (1992). Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 86:38-46.
153. Reed JC (1994). Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6.
154. Reiss K, Cheng W, Ferber A, Kajstura J, Li P, Li B, Olivetti G, Homey CJ, Baserga R, and Anversa P (1996a). Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci USA 93:8630-8635.
155. Reiss K, Cheng W, Giordano A, De Luca A, Li B, Kajstura J, and Anversa P (1996b). Myocardial infarction is coupled with the activation of cyclins and cyclin dependent kinases in myocytes. Exp Cell Res 225:44-54.
156. Reiss K, Cheng W, Pierzchalski P, Kodali S, Li B, Wang S, Liu Y, and Anversa P (1997). Insulin-like growth factor-1 receptor and its ligand regulate the reentry of adult ventricular myocytes into the cell cycle. Exp Cell Res 235:198-209.
157. 1 autocrine system, enhanced expression of late growth related genes, DNA-synthesis and myocyte nuclear mitotic division in rats. Exp Cell Res 207:348-360.
158. Reiss K, Kajstura J, Zhang X, Li P, Szoke E, Olivetti G, and Anversa P (1994). Acute myocardial infarction leads to up-regulation of the IGF-1 autocrine system, DNA replication, and nuclear mitotic division in the remaining viable cardiac myocytes. Exp Cell Res 213:463-472.
159. 1-receptor and late growth related genes in ventricular myocytes acutely after infarction in rats. J Cell Physiol 158:160-168.
160. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P, and Baserga R (1995). The insulin like growth factor 1 receptor protects tumor cells from apoptosis in vitro. Cancer Res 55:2463-2469.
161. Riedy MC, Muirhead KA, Jensen CP, and Stewart CC (1991). Use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations. Cytometry 12:133-139.
162. Roberts WC (1976). The coronary arteries and left ventricle in clinically isolated angina pectoris: A necropsy analysis. Circulation 54:388-390.
163. Rodriguez-Tarduchy G, Collins MK, Garcia I, and Lopez-Rivas A (1992). Insulin-like growth factor-1 inhibits apoptosis in IL-3-dependent hemopoietic cells. J Immunol 149:535-540.
164. Roychoudhury R, Jay E, and Wu R (1976). Terminal labeling and addition of homopolymer tracts to duplex DNA fragments by terminal deoxynucleotidyl transferase. Nucleic Acid Res 3:863-877.
165. Sakahira H, Enari M, and Nagata S (1998). Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96-99.
166. Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, and Aakhus T (1993). Heart volume and cardiovascular mortality: A 16 year follow-up study of 1984 healthy middle aged men. Eur Heart J 14:592-596.
167. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, and Bleese N (1991). Impairment of myocardial ultrastructure and changes of the
168. Scheid MP, Lauener RW, and Duronio V (1995). Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoetic cells: Phosphatidylinositol 3-OH kinase inhibitors reveal a difference in signaling between interleukin-3 and granulocyte-macrophage colony stimulating factor. Biochem J 312:159-162.
169. Schneider JW, Gu W, Zhu L, Mahdavi V, and Nadal-Ginard B (1994). Reversal of terminal differentiation mediated by p107 in Rb(-/-) muscle cells. Science 264:1467-1471.
170. Schneider MD (1996). Myocardial infarction as a problem of growth control: Cell cycle therapy for cardiac myocytes? J Cardiac Failure 2:259-263.
171. Schuster EH and Bulkley BH (1980). Ischemic cardiomyopathy: A clinicopathologic study of fourteen patients. Am Heart J 100:506-512.
172. Sen A, Dunnmon P, Henderson SC, Gerard RD, and Chien KR (1988). Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen. J Biol Chem 163:19132-19136.
173. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, and Goldstein S (1996). Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 148:141-149.
174. Shimizu S, Eguchi Y, Kamiike W, Matsuda H, and Yoshihide T (1996). Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 12:2251-2257.
175. Simpson PC (1989). Proto-oncogenes and cardiac hypertrophy. Annu Rev Physiol 51:189-202.
176. Skalli O, Gabbiani G, Babai F, Seemayer TA, Pizzolato G, and Schurch W (1988). Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas. Am J Pathol 130:515-531.
177. Sollner-Webb B, Melchior W Jr, and Felsenfeld G (1978). DNAse I, DNAse II and staphylococcal nuclease cut at different, yet symmetrically located, sites in the nucleosome core. Cell 14:611-627.
178. Sommers HM and Jennings RB (1964). Experimental acute myocardial infarction. Histologic and histochemical studies of early myocardial infarcts induced by temporary or permanent occlusion of a coronary artery. Lab Invest 13:1491-1503.
179. Soonpaa MH and Field LJ (1997). Assessment of cardiomyocyte DNA synthesis in the normal and injured adult mouse heart. Am J Physiol 272:H220-H226.
180. Soonpaa MH, Kim KK, Pajak L, Franklin M, and Field LJ (1996). Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol 271:H2183-H2189.
181. Soonpaa MH, Koh GY, Klug MG, and Field LJ (1994). Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264:98-101.
182. Soonpaa MH, Koh GY, Pajak L, Jing S, Wang H, Franklin MT, Kim KK, and Field LJ (1997). Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest 99:2644-2654.
183. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, and Van Dyke T (1994). p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703-711.
184. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, and Hiroe M (1994). Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 75:426-433.
185. Teiger E, Dam T-V, Richard L, Wisnewsky C, Tea B-S, Gaboury L, Tremblay J, Schwartz K, and Hamet P (1996). Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest 97:2891-2897.
186. Thatte U and Dahanukar S (1997). Apoptosis. Clinical relevance and pharmacological manipulation. Drugs 54:511-532.
187. Valente M, Calabrese F, Thiene G, Angelini A, Basso C, Nava A, and Rossi L (1998). In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol 152:479-484.
188. Van Dyck JM and Wattiaux R (1968). Distribution intracellulaire de l'exonuclease acide dans le foie de rat. Eur J Biochem 7:13-20.
189. Veis DJ, Sorenson CM, Shutter JR, and Korsmeyer SJ (1993). Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240.
190. Warnes CA and Roberts WC (1984). Sudden coronary death: Relation of amount and distribution of coronary narrowing at necropsy to previous symptoms of myocardial ischemia, left ventricular scarring and heart weight. Am J Cardiol 54:65-73.
191. Warren SE, Royald HD, Markis JE, Grossman W, and McKay RG (1988). Time course of left ventricular dilation after myocardial infarction: Influence of infarct-related artery and success of coronary thrombolysis. J Am Coll Cardiol 11:12-19.
192. Weber KT and Brilla CG (1991). Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensinaldosterone system. Circulation 83:1849-1865.
193. Weber KT, Janicki JS, Shroff SG, Pick R, Cheng RM, and Bashey RI (1988). Collagen remodeling of the pressure overloaded, hypertrophied nonhuman primate myocardium. Circ Res 62:757-765.
194. Weinberg RA (1996). E2F and cell proliferation: A world turned upside down. Cell 85:457-459.
195. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, and Healy B (1988). Cellular mechanisms of myocardial infarct expansion. Circulation 78:186-201.
196. Wu X and Levine AJ (1994). p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91:3602-3606.
197. Wyllie A (1998). An endonuclease at last. Nature 391:20-21.
198. Wyllie AH, Arends MJ, Morris RG, Walker SW, and Evan G (1992). The apoptosis endonuclease and its regulation. Semin Immunol 4:381-387.
199. Wyllie AH, Morris RG, Smith AL, and Dunlop D (1984). Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67-77.
200. Yao R and Cooper GM (1995). Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003-2006.
201. Yaoita H, Ogawa K, Maehara K, and Maruyama Y (1998). Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97:276-281.
202. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, and Oren M (1991). Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347.
203. Yoshizumi M, Lee W-S, Hsieh C-M, Tsai J-C, Li J, Perrella MA, Patterson C, Endege WO, Schlegel R, and Lee M-E (1995). Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat heart. J Clin Invest 95:2275-2280.
204. Zak R (1974). Development and proliferative capacity of cardiac muscle cells. Circ Res 35:17-26.
205. Zamzami N, Susin A, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, and Kroemer G (1996). Mitochondrial control of nuclear apoptosis. J Exp Med 183:1533-1544.
206. Zha HB, Aime-Sempe C, Sato T, and Reed JC (1996a). Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BHI and BH2. J Biol Chem 271:7440-7444.
207. L. Cell 87:619-628.
208. Zhan Q, Carrier F, and Fornance AJ (1993). Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol 13:4242-4250.